Ben Tre Pharmaceutical JSC (VN:DBT) — Stock Price
Ben Tre Pharmaceutical JSC (VN:DBT) is currently trading at ₫13050.00 VND, down 3.33% today. Over the past 52 weeks, shares have ranged between ₫10000.00 and ₫13900.00. This page tracks Ben Tre Pharmaceutical JSC's live share price on the VN exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Ben Tre Pharmaceutical JSC market cap and net worth.
Ben Tre Pharmaceutical JSC (DBT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Ben Tre Pharmaceutical JSC's daily closing share price and trading volume on the VN exchange over the past year, giving a clear view of recent price momentum and liquidity.
Ben Tre Pharmaceutical JSC Income Statement — Revenue, Profit & Earnings by Year
Ben Tre Pharmaceutical JSC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year |
|---|
| Total Revenue |
| Cost of Revenue |
| Gross Profit |
| Research & Development |
| SG&A |
| Total Operating Expenses |
| Operating Income |
| EBITDA |
| EBIT |
| Interest Expense |
| Income Before Tax |
| Income Tax Expense |
| Net Income |
Ben Tre Pharmaceutical JSC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Ben Tre Pharmaceutical JSC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year |
|---|
| Total Assets |
| Total Current Assets |
| Cash & Equivalents |
| Short-term Investments |
| Net Receivables |
| Inventory |
| Property, Plant & Equipment |
| Goodwill |
| Total Liabilities |
| Total Current Liabilities |
| Long-term Debt |
| Net Debt |
| Total Stockholder Equity |
| Retained Earnings |
Ben Tre Pharmaceutical JSC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Ben Tre Pharmaceutical JSC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Operating Cash Flow | ₫-74.12 Billion | ₫-10.81 Billion | ₫51.07 Billion | ₫32.71 Billion |
| Capital Expenditures | ₫6.82 Billion | ₫10.51 Billion | ₫9.02 Billion | ₫4.50 Billion |
| Free Cash Flow | — | — | — | — |
| Investing Cash Flow | ₫-42.40 Billion | ₫8.10 Billion | ₫-53.13 Billion | ₫-33.29 Billion |
| Financing Cash Flow | ₫103.66 Billion | ₫-17.24 Billion | ₫29.69 Billion | ₫-2.48 Billion |
| Dividends Paid | ₫13.53 Billion | ₫18.34 Billion | ₫12.28 Billion | ₫7.68 Billion |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | ₫13.34 Billion | ₫13.01 Billion | ₫11.78 Billion | ₫4.54 Billion |
| Change in Cash | ₫-12.85 Billion | ₫-19.95 Billion | ₫27.63 Billion | ₫-3.06 Billion |
Ben Tre Pharmaceutical JSC Earnings History — EPS Actual vs. Analyst Estimates
Track Ben Tre Pharmaceutical JSC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 26.31 | — | — |
| Jun 30, 2025 | 471.37 | — | — |
| Mar 31, 2025 | 120.89 | — | — |
| Dec 31, 2024 | 193.93 | — | — |
| Sep 30, 2024 | 102.10 | — | — |
| Jun 30, 2024 | 46.60 | — | — |
| Mar 31, 2024 | 371.41 | — | — |
| Dec 31, 2023 | 313.23 | — | — |